Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 493


Long-Term Outcomes of Biliopancreatic Diversion on Glycemic Control, Insulin Sensitivity and Beta Cell Function.

Vasques AC, Pareja JC, da Saúde de Oliveira M, Novaes FS, Lima MM, Chaim ÉA, Piccinini F, Dalla Man C, Cobelli C, Geloneze B.

Obes Surg. 2016 Nov;26(11):2572-2580.


Psychological outcomes of evening and night closed-loop insulin delivery under free living conditions in people with Type 1 diabetes: a 2-month randomized crossover trial.

Kropff J, DeJong J, Del Favero S, Place J, Messori M, Coestier B, Farret A, Boscari F, Galasso S, Avogaro A, Bruttomesso D, Cobelli C, Renard E, Magni L, DeVries JH; AP@home consortium..

Diabet Med. 2016 Oct 1. doi: 10.1111/dme.13268.


The Genetic Landscape of Renal Complications in Type 1 Diabetes.

Sandholm N, Van Zuydam N, Ahlqvist E, Juliusdottir T, Deshmukh HA, Rayner NW, Di Camillo B, Forsblom C, Fadista J, Ziemek D, Salem RM, Hiraki LT, Pezzolesi M, Trégouët D, Dahlström E, Valo E, Oskolkov N, Ladenvall C, Marcovecchio ML, Cooper J, Sambo F, Malovini A, Manfrini M, McKnight AJ, Lajer M, Harjutsalo V, Gordin D, Parkkonen M; FinnDiane Study Group, Tuomilehto J, Lyssenko V, McKeigue PM, Rich SS, Brosnan MJ, Fauman E, Bellazzi R, Rossing P, Hadjadj S, Krolewski A, Paterson AD; DCCT/EDIC Study Group, Florez JC, Hirschhorn JN, Maxwell AP; GENIE Consortium, Dunger D, Cobelli C, Colhoun HM, Groop L, McCarthy MI, Groop PH; SUMMIT Consortium.

J Am Soc Nephrol. 2016 Sep 19. pii: ASN.2016020231. [Epub ahead of print]


Altered EMG patterns in diabetic neuropathic and not neuropathic patients during step ascending and descending.

Spolaor F, Sawacha Z, Guarneri G, Del Din S, Avogaro A, Cobelli C.

J Electromyogr Kinesiol. 2016 Aug 20;31:32-39. doi: 10.1016/j.jelekin.2016.08.007. [Epub ahead of print]


Mechanisms underlying the pathogenesis of isolated impaired glucose tolerance in humans.

Varghese RT, Dalla Man C, Sharma A, Viegas I, Barosa C, Marques C, Shah M, Miles JM, Rizza RA, Jones JG, Cobelli C, Vella A.

J Clin Endocrinol Metab. 2016 Sep 7:jc20161998.


Response to Comment on Kovatchev and Cobelli. Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes. Diabetes Care 2016;39:502-510.

Kovatchev B, Cobelli C.

Diabetes Care. 2016 Sep;39(9):e157-8. doi: 10.2337/dci16-0019. No abstract available.


Oxytocin Improves Beta-Cell Responsivity and Glucose Tolerance in Healthy Men.

Klement J, Ott V, Rapp K, Brede S, Piccinini F, Cobelli C, Lehnert H, Hallschmid M.

Diabetes. 2016 Aug 23. pii: db160569. [Epub ahead of print]


Insulin Infusion Set Use: European Perspectives and Recommendations.

Deiss D, Adolfsson P, Alkemade-van Zomeren M, Bolli GB, Charpentier G, Cobelli C, Danne T, Girelli A, Mueller H, Verderese CA, Renard E.

Diabetes Technol Ther. 2016 Sep;18(9):517-24. doi: 10.1089/dia.2016.07281.sf. Epub 2016 Aug 15.


From Two to One Per Day Calibration of Dexcom G4 Platinum by a Time-Varying Day-Specific Bayesian Prior.

Acciaroli G, Vettoretti M, Facchinetti A, Sparacino G, Cobelli C.

Diabetes Technol Ther. 2016 Aug;18(8):472-9. doi: 10.1089/dia.2016.0088.


Facial feedback and autonomic responsiveness reflect impaired emotional processing in Parkinson's Disease.

Balconi M, Pala F, Manenti R, Brambilla M, Cobelli C, Rosini S, Benussi A, Padovani A, Borroni B, Cotelli M.

Sci Rep. 2016 Aug 11;6:31453. doi: 10.1038/srep31453.


Model individualization for artificial pancreas.

Messori M, Toffanin C, Del Favero S, De Nicolao G, Cobelli C, Magni L.

Comput Methods Programs Biomed. 2016 Jul 5. pii: S0169-2607(15)30443-0. doi: 10.1016/j.cmpb.2016.06.006. [Epub ahead of print]


Standardized Mixed-Meal Tolerance and Arginine Stimulation Tests Provide Reproducible and Complementary Measures of β-Cell Function: Results From the Foundation for the National Institutes of Health Biomarkers Consortium Investigative Series.

Shankar SS, Vella A, Raymond RH, Staten MA, Calle RA, Bergman RN, Cao C, Chen D, Cobelli C, Dalla Man C, Deeg M, Dong JQ, Lee DS, Polidori D, Robertson RP, Ruetten H, Stefanovski D, Vassileva MT, Weir GC, Fryburg DA; Foundation for the National Institutes of Health β-Cell Project Team.

Diabetes Care. 2016 Sep;39(9):1602-13. doi: 10.2337/dc15-0931. Epub 2016 Jul 12.


How Much Is Short-Term Glucose Prediction in Type 1 Diabetes Improved by Adding Insulin Delivery and Meal Content Information to CGM Data? A Proof-of-Concept Study.

Zecchin C, Facchinetti A, Sparacino G, Cobelli C.

J Diabetes Sci Technol. 2016 Sep;10(5):1149-60. doi: 10.1177/1932296816654161.


Improving Efficacy of Inhaled Technosphere Insulin (Afrezza) by Postmeal Dosing: In-silico Clinical Trial with the University of Virginia/Padova Type 1 Diabetes Simulator.

Visentin R, Giegerich C, Jäger R, Dahmen R, Boss A, Grant M, Dalla Man C, Cobelli C, Klabunde T.

Diabetes Technol Ther. 2016 Sep;18(9):574-85. doi: 10.1089/dia.2016.0128.


The Artificial Pancreas in 2016: A Digital Treatment Ecosystem for Diabetes.

Kovatchev B, Tamborlane WV, Cefalu WT, Cobelli C.

Diabetes Care. 2016 Jul;39(7):1123-6. doi: 10.2337/dc16-0824. No abstract available.


Interstitial Fluid Glucose Is Not Just a Shifted-in-Time but a Distorted Mirror of Blood Glucose: Insight from an In Silico Study.

Cobelli C, Schiavon M, Dalla Man C, Basu A, Basu R.

Diabetes Technol Ther. 2016 Aug;18(8):505-11. doi: 10.1089/dia.2016.0112. Epub 2016 Jun 2.


Glucose Variability: Timing, Risk Analysis, and Relationship to Hypoglycemia in Diabetes.

Kovatchev B, Cobelli C.

Diabetes Care. 2016 Apr;39(4):502-10. doi: 10.2337/dc15-2035.


Randomized Summer Camp Crossover Trial in 5- to 9-Year-Old Children: Outpatient Wearable Artificial Pancreas Is Feasible and Safe.

Del Favero S, Boscari F, Messori M, Rabbone I, Bonfanti R, Sabbion A, Iafusco D, Schiaffini R, Visentin R, Calore R, Moncada YL, Galasso S, Galderisi A, Vallone V, Di Palma F, Losiouk E, Lanzola G, Tinti D, Rigamonti A, Marigliano M, Zanfardino A, Rapini N, Avogaro A, Chernavvsky D, Magni L, Cobelli C, Bruttomesso D.

Diabetes Care. 2016 Jul;39(7):1180-5. doi: 10.2337/dc15-2815. Epub 2016 May 10.


Day-and-Night Closed-Loop Glucose Control in Patients With Type 1 Diabetes Under Free-Living Conditions: Results of a Single-Arm 1-Month Experience Compared With a Previously Reported Feasibility Study of Evening and Night at Home.

Renard E, Farret A, Kropff J, Bruttomesso D, Messori M, Place J, Visentin R, Calore R, Toffanin C, Di Palma F, Lanzola G, Magni P, Boscari F, Galasso S, Avogaro A, Keith-Hynes P, Kovatchev B, Del Favero S, Cobelli C, Magni L, DeVries JH; AP@home Consortium.

Diabetes Care. 2016 Jul;39(7):1151-60. doi: 10.2337/dc16-0008. Epub 2016 May 5.


Multinational Home Use of Closed-Loop Control Is Safe and Effective.

Anderson SM, Raghinaru D, Pinsker JE, Boscari F, Renard E, Buckingham BA, Nimri R, Doyle FJ 3rd, Brown SA, Keith-Hynes P, Breton MD, Chernavvsky D, Bevier WC, Bradley PK, Bruttomesso D, Del Favero S, Calore R, Cobelli C, Avogaro A, Farret A, Place J, Ly TT, Shanmugham S, Phillip M, Dassau E, Dasanayake IS, Kollman C, Lum JW, Beck RW, Kovatchev B; Control to Range Study Group.

Diabetes Care. 2016 Jul;39(7):1143-50. doi: 10.2337/dc15-2468. Epub 2016 Apr 13.

Items per page

Supplemental Content

Loading ...
Support Center